Centene Corporation
CNC Healthcare Healthcare Plans
Centene Corporation’s revenue for fiscal 2025 (year ended December 2025) was $194.8 billion, up 19.4% from fiscal 2024. In the quarter to June 2026, revenue grew 9.92%, EPS grew 533.3%, free cash flow grew 116.6% and total debt fell 8.37%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years.
Follow CNC
Centene Corporation (CNC) EPS (diluted)
Centene Corporation's EPS (diluted) for fiscal 2025 was −$13.53, compared with $6.31 in fiscal 2024. Over the twelve months to 30 June 2026 it was −$10.44. Over the past ten years it has ranged from −$13.53 (fiscal 2025) to $6.31 (fiscal 2024) — the current reading is the lowest in ten years. Centene Corporation ranks 12th of 12 Healthcare Plans companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2025 | −$13.53 | — |
| FY2024 | $6.31 | 27.47% |
| FY2023 | $4.95 | 139.13% |
| FY2022 | $2.07 | (9.21%) |
| FY2021 | $2.28 | (26.92%) |
| FY2020 | $3.12 | (0.64%) |
| FY2019 | $3.14 | 38.94% |
| FY2018 | $2.26 | (3.62%) |
| FY2017 | $2.35 | 36.73% |
| FY2016 | $1.72 | 19.10% |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Jun 2026 | $2.19 | (29.58%) |
| Mar 2026 | $3.11 | — |
| Dec 2025 | −$2.24 | — |
| Sep 2025 | −$13.50 | — |
| 42 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| CI Cigna Group compare | $24.17 |
| ELV Elevance Health, Inc. compare | $22.50 |
| UNH UnitedHealth Group Incorporated compare | $15.54 |
| HUM Humana Inc. compare | $10.57 |
| CVS CVS Health Corporation compare | $3.78 |
| OSCR Oscar Health, Inc. compare | $1.40 |
| CLOV Clover Health Investments, Corp. compare | −$0.05 |
| MOH Molina Healthcare, Inc compare | −$0.18 |
| CNC Centene Corporation | −$10.44 |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on CNC
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement